Celerion at AAPS 2026 PharmSci 360
Oct 25–28, 2026 New Orleans, LA ~4k attendees Website
Celerion brings 4 presentations to AAPS 2026 PharmSci 360 in New Orleans. Its program centres on bioanalytical assay performance, including neutralizing antibody tests that tolerate drug, anti-bevacizumab antibody detection and microsampling. Its work also shows how the choice of diluent changed selectivity in a biomarker assay.
| Organization | AAPS 2026 PharmSci 360 Attendance |
|---|---|
Celerion Lincoln, NE | |
Clinical research organization running early-phase clinical pharmacology studies alongside bioanalytical laboratory services. | Poster Mon Oct 26 10:30am–11:30am A Novel Integrated Strategy to Enhance Drug Tolerance in Neutralizing Antibody Assays Poster Tue Oct 27 9:30am–10:30am A Tale of Two Matrices: How Diluent Type Influenced Selectivity in a Biomarker Assay Poster Tue Oct 27 2:30pm–3:30pm Development and Validation of a PandA Assay for Detection of Anti-Bevacizumab Antibodies Session Tue Oct 27 3:00pm–4:00pm Rapid Fire: Navigating Bioanalytical Complexity: Assay Performance, Biomarker Platforms, and Microsampling |
Instantly find 20 buyers from Celerion
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Association of Pharmaceutical Scientists (AAPS). Submit a correction